• LIVE MARKETS

  • Loading content...
Shanghai Fosun to buy Gland Pharma for $1.4 bn

Shanghai Fosun to buy Gland Pharma for $1.4 bn

Rare deal of a Chinese drug firm buying an Indian company likely this week

Related: Advent, Baxter ready bids for Gland Pharma: Sources

OPINION 

COLUMNISTS

Trade policy and Brexit

Deepak Lal

The UK must acknowledge that foreign trade is a positive-sum game, and the correct policy is a unilateral adoption of free trade

Reservoir of untapped rights

M J Antony

The Supreme Court takes the law of torts a few steps forward

EDITORIAL COMMENT

No broad-based revival

Early-bird corporate results offer hope but no clear trend

Honouring treaties

Questions arising out of Antrix-Devas arbitration

MARKETS

PEOPLE

POLL

Will Verizon be able to make Yahoo! the Internet behemoth it was at one time?

  • Yes
  • No
  • Can't Say

PERSONAL FINANCE

Didn’t quote PAN with high-value transactions? Read this

Didn't quote PAN with high-value transactions? Read this

Remember, the onus is on you to prove that income has been declared and tax has been paid

Technology

Inside Chennai's world of 3D illusions

Is 'glasses-free' 3D coming soon to a theater near you?

TV sets use a series of slits in front of screen that allow each eye to see a different set of pixels, creating a simulated sense of depth

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard